Yes. One Author of all abstracts selected for Oral and ePoster Presentation must attend the Annual Meeting in-person to deliver a LIVE presentation. There is no option for virtual presentation.
All abstracts accepted for oral or ePoster presentation at the ACAAI 2024 Annual Meeting must be presented in-person. Presenting Authors who are unable to register for in-person Annual Meeting attendance and travel to Boston to present their abstract will have the opportunity to designate a co-Author to serve as the Presenting Author. If no co-Authors are available to present, the abstract must be withdrawn by the submission deadline date. Failure to deliver an in-person presentation for an accepted oral and poster abstracts may result in the loss of future abstract submission and authorship privileges.
Research Abstracts – Open: April 1, 2024 – Close: July 8, 2024 - 5:00 pm (CDT)
Medically Challenging Case Abstracts – Open: April 1, 2024 – Close: August 1, 2024 - 5:00 pm (CDT)
Late Breaking Abstracts - August 26, 2024 - September 25, 2024 - 5:00 pm (CDT) Click here for important details on Late Breaking Abstract submission.
Note: Due to publication deadlines, the abstract submission deadlines will not be extended.
No. ACAAI only accepts original abstracts. Abstracts previously accepted and/or published by other organizations should not be submitted. If an abstract submitted to ACAAI Annual Meeting is accepted for programming and/or publication by another organization prior to its acceptance by ACAAI, it must be withdrawn from consideration for the ACAAI Annual Meeting.
There is a $60 non-refundable fee for each Research and Medically Challenging Case abstract submission.
There is a $250 non-refundable fee for each Late-breaking abstract submission.
No changes can be made after the submission deadline has closed.
No. Abstracts can be submitted by Members and Non-Members of ACAAI.
Yes. A non-Author can submit and be the main point of contact for an abstract.
Click here for guidance on adding Authors to your Abstract.
Research Abstracts are allowed a total of 8 Authors.
Medically Challenging Case Abstracts are allowed a total of 5 Authors.
Late Breaking Abstracts are allowed an unlimited number of Authors.
No. You are welcome to submit an unlimited number of abstracts. However, an Author can only be listed as a Presenting Author on one abstract.
Yes. Any listed author who has completed a Disclosure by the submission deadline date can become the Presenting Author. Note, however, that the Presenting Author as shown within our system as of the deadline date, will appear as the Presenting Author in any online publication of the abstract.
What is the ACAAI Policy on the use of generative artificial intelligence (AI)?
ACAAI recognizes the use of generative artificial intelligence (AI) as a powerful tool for educators and researchers and encourages its responsible and ethical use. If any form of generative AI is utilized for this abstract submission, it must be clearly acknowledged in the appropriate section(s) within the abstract content. It is expected that authors will review any AI-generated copy, figures, images, citations, or statements for accuracy and edit accordingly. Presenting inaccurate AI-generated information or failing to acknowledge AI-generated information will result in disqualification.
Yes. All disclosures must be fully completed by the abstract deadline. Any author who has failed to complete their disclosure will be removed from the abstract and will not appear in any published/online use of the abstract.
Once the Submitter has entered the names and email address(es) of the author(s) and pressed the “submit” or “save and edit later” button, an email is automatically sent to each listed author that includes a link to their individual disclosures.
Note: Each time the submitter clicks the “submit” or “save and edit later” button, a new email, with a modified link, will be sent to any author who has not completed their disclosure. All previously sent links will be rendered invalid.
Login to your abstract. Click the edit abstract icon. Click the "Save and Edit Later" or "Submit Abstract" button. Any authors who have not completed a disclosure will be sent an email with a link to complete their disclosure.
When will authors be notified of the Abstract Review Committee’s decision?
Research and Medically Challenging Case abstract submitters will be notified of the decision in late-August/early-September. It is the responsibility of the abstract submitter to notify any additional authors. Late-breaking abstract submitters will be notified on September 30, 2024.
All accepted abstracts will be published in the ACAAI’s Annals of Allergy, Asthma & Immunology – October, 2024 Online Supplement. ePosters with audio/video recording will be also available for online viewing.
All accepted abstracts, ePosters, and oral presentation slides are embargoed until October 24, 2024 - 8:00 am (ET). Authors are permitted to share only the abstract title, date of oral/ePoster presentation, and presenter name in any communication prior to October 24, 2024.
Please contact Hollis Heavenrich-Jones, Director of Public Relations at hollisheavenrich-jones@acaai.org for information and assistance.
General ePosters can include a QR Code or Bar Code only to direct the viewer to additional education information. QR Codes and Bar Codes cannot direct the viewer to any promotional materials or information.
ePosters that are created from abstracts presented during an Oral Abstract session cannot include a QR Code or Bar Code.
No. QR Codes and/or Bar Codes cannot be included in any presentation during educational sessions presented during the Annual Meeting.
Abstracts can be withdrawn at anytime during the submission period. No abstracts can be withdrawn after the close of the submission period. Requests for withdrawal must be submitted in writing to maureenknight@acaai.org.
Yes. However, ACAAI may allow reuse upon written request from the first author. Contact maureenknight@acaai.org to request permission.
| No FAQ Found |